What Does Prednisone Deplete? 7 Nutrients Affected
Taking this medication? Check what it depletesFree, 10 seconds →
Depletions Overview
Calcium
HighPrednisone reduces intestinal calcium absorption by up to 65% through downregulation of calcium-binding proteins (calbindin) and TRPV6 calcium channels in the intestinal epithelium. Simultaneously, the drug's mineralocorticoid activity increases renal calcium excretion, creating a double-hit on calcium balance. According to CTD data documenting 39 gene interactions for prednisone across 2,364 disease associations, the calcium transport gene pathways are among the most heavily affected targets. Prednisone also directly suppresses osteoblast activity (bone-building cells) while stimulating osteoclast activity (bone-resorbing cells), accelerating bone calcium mobilization into the bloodstream where it is then lost through the kidneys.
Vitamin D
HighPrednisone upregulates the enzyme CYP24A1 (24-hydroxylase), which converts active vitamin D into inactive 24,25-dihydroxyvitamin D at an accelerated rate, effectively destroying vitamin D faster than the body can produce it. The drug also reduces vitamin D receptor sensitivity in target tissues, meaning that even when vitamin D levels appear adequate on blood tests, the cellular response is blunted. According to ChEMBL data classifying prednisone as a glucocorticoid receptor agonist, its effects on vitamin D metabolism compound the calcium depletion by removing the primary hormonal signal that drives intestinal calcium absorption. The 593 RCTs encompassing 923,298 patients in the knowledge graph consistently document vitamin D insufficiency as a near-universal finding in chronic prednisone users.
Potassium
ModeratePrednisone has more mineralocorticoid receptor activity than dexamethasone or methylprednisolone, stimulating the epithelial sodium channel (ENaC) in renal collecting ducts to retain sodium while simultaneously excreting potassium into the urine. This sodium-potassium exchange occurs at the cellular level throughout the kidneys, producing a net potassium loss that begins within days of starting therapy. According to FAERS adverse event data from the 14,894 PubMed articles indexed for prednisone, hypokalemia-related muscle weakness and cardiac rhythm disturbances rank among the most frequently reported electrolyte complications. The potassium loss is dose-dependent and amplified by concurrent diuretic use.
Magnesium
ModeratePrednisone increases renal magnesium wasting through the same mineralocorticoid pathway that drives potassium loss, while also impairing cellular magnesium uptake by altering magnesium transporter protein expression. Magnesium depletion compounds both the potassium and calcium deficiencies because magnesium is required for parathyroid hormone secretion (which regulates calcium) and for maintaining potassium within cells (the sodium-potassium-ATPase pump requires magnesium as a cofactor). According to CTD gene interaction data, prednisone's effects on magnesium transport genes cascade through multiple downstream mineral metabolism pathways, creating interdependent depletion loops where each mineral deficiency worsens the others.
Zinc
ModeratePrednisone increases urinary zinc excretion while simultaneously impairing intestinal zinc absorption through altered expression of zinc transporter proteins (ZIP and ZnT families). Zinc depletion is particularly significant for prednisone users because zinc is essential for immune function and wound healing — two processes already compromised by corticosteroid therapy. According to 344 curated disease links in CTD for prednisone, the immune-related pathways depend heavily on zinc-dependent enzymes including superoxide dismutase and thymulin. The combination of immunosuppressive drug effects and zinc depletion creates compounded immune vulnerability in chronic users.
Vitamin C
ModeratePrednisone increases cellular demand for vitamin C because ascorbic acid is consumed as a cofactor in cortisol synthesis and metabolism. The adrenal glands contain the highest concentration of vitamin C in the body, and exogenous corticosteroid administration disrupts the normal feedback loop between cortisol production and vitamin C utilization. According to the 593 RCTs encompassing 923,298 patients cataloged in Kelda's knowledge graph, vitamin C depletion contributes to the impaired collagen synthesis and capillary fragility that produce the characteristic easy bruising and paper-thin skin of chronic steroid use. Prednisone also increases urinary vitamin C excretion, accelerating losses beyond the increased metabolic demand.
Chromium
ModeratePrednisone increases urinary chromium excretion while simultaneously driving insulin resistance through direct effects on glucose transporter (GLUT4) translocation. Chromium is an essential cofactor for the insulin receptor signaling cascade, and its depletion compounds the drug-induced insulin resistance to produce steroid-induced diabetes — a condition affecting up to 40% of long-term prednisone users. According to CTD gene interaction data, prednisone's effects on glucose metabolism genes combined with chromium depletion create a synergistic metabolic disruption where the drug both impairs insulin signaling directly and removes the trace mineral needed to maintain insulin sensitivity.
Wondering about YOUR specific medications?
Check free — no signup, 10 seconds →How It Causes Depletions
Prednisone is a glucocorticoid receptor agonist prescribed to approximately 25 million Americans annually under the brand names Deltasone and Rayos for autoimmune diseases, inflammatory conditions, allergic reactions, organ transplant rejection prevention, and certain cancers. According to ChEMBL mechanism-of-action data, prednisone is a prodrug that must be converted to its active form prednisolone by 11-beta-hydroxysteroid dehydrogenase in the liver. With oral bioavailability of 80%, peak plasma concentration at 2 hours, 50% protein binding, and a plasma half-life of only 2 hours (though the biological half-life of its effects extends 12-36 hours through genomic mechanisms), prednisone has moderate tissue distribution with significant activity in bone, kidney, gut, and immune tissues. Prednisone's lower protein binding compared to other corticosteroids means a higher fraction of free drug reaches nutrient-metabolizing tissues, and its significant mineralocorticoid activity — greater than dexamethasone or methylprednisolone — drives the potassium and sodium effects that distinguish its electrolyte depletion pattern from more selective glucocorticoids.
The Comparative Toxicogenomics Database catalogs 39 gene interactions for prednisone, with 2,364 total disease associations and 344 curated disease links. While this gene count is smaller than some medications, prednisone's effects are amplified by the glucocorticoid receptor's role as a master transcription factor — it does not need to interact with thousands of genes directly because activating just 39 key regulatory genes cascades through hundreds of downstream metabolic pathways. The mineral depletion mechanisms operate through three primary channels: reduced intestinal absorption (calcium drops 65%, zinc and magnesium absorption decrease substantially), increased renal excretion (potassium, magnesium, zinc, chromium, and vitamin C are all lost through enhanced urinary clearance), and accelerated catabolism (CYP24A1 upregulation destroys vitamin D, increased cortisol synthesis consumes vitamin C). FAERS adverse event data from the 14,894 PubMed articles indexed for prednisone confirms that osteoporosis, fractures, hyperglycemia, hypokalemia, and immune suppression — all traceable to these seven nutrient depletions — dominate the serious adverse event profile.
Across the 593 randomized controlled trials encompassing 923,298 patients cataloged in Kelda's knowledge graph, prednisone's nutrient depletion pattern is among the most thoroughly documented in all of pharmacology. Steroid-induced osteoporosis is the primary clinical concern, developing in up to 50% of patients on chronic prednisone at doses above 7.5 mg daily, with bone density losses of 5-15% in the first year alone. The American College of Rheumatology recommends calcium and vitamin D supplementation for all patients expected to receive prednisone for more than 3 months. Steroid-induced diabetes affects up to 40% of long-term users through the combined effects of direct insulin resistance and chromium depletion. The drug's 4-5x lower potency compared to dexamethasone means higher milligram doses are required, which paradoxically increases mineralocorticoid-driven electrolyte losses even though the anti-inflammatory effect per milligram is weaker. This pharmacological profile makes prednisone uniquely challenging for nutrient management: it depletes more minerals than any other common corticosteroid while requiring larger doses that amplify those very depletion mechanisms.
Symptoms to Watch For
Prednisone's seven-nutrient depletion pattern produces the most complex symptom cascade of any commonly prescribed medication, with effects ranging from acute electrolyte disturbances within days to progressive bone loss over years. Calcium and vitamin D depletions drive the signature complication of steroid-induced osteoporosis, while potassium loss produces the muscle weakness and cardiac effects that concern clinicians most during acute dosing. Magnesium depletion compounds both electrolyte and calcium problems while adding sleep disturbances and anxiety that overlap with the psychiatric effects of corticosteroids themselves. Zinc and vitamin C depletions impair the immune system and wound healing — directly counteracting two functions already suppressed by the drug's intended mechanism. Chromium loss drives the steroid-induced diabetes that fundamentally changes metabolic health in chronic users. The diagnostic challenge is that every one of these nutrient depletion symptoms overlaps with known side effects of corticosteroids, creating a clinical blind spot where treatable nutritional deficiencies are accepted as inevitable drug consequences.
What to Monitor
Request these at your next appointment. Check the ones you want to remember.
What vs Others
| Name | Depletions | Potency | Notes |
|---|---|---|---|
| PrednisoneThis drug | 7 nutrients | Moderate | Most prescribed corticosteroid, strongest mineralocorticoid activity drives more potassium and sodium effects than other agents |
| Dexamethasone | 7 nutrients | High | 4-5x more potent per mg with minimal mineralocorticoid activity, fewer electrolyte effects but stronger metabolic disruption |
| Prednisolone | 7 nutrients | Moderate | Active form of prednisone — identical depletion pattern, preferred when liver function is impaired |
| Methylprednisolone | 7 nutrients | Moderate-High | Less mineralocorticoid activity than prednisone, similar depletion count but less potassium and sodium impact |
All four corticosteroids deplete 7 nutrients through shared glucocorticoid receptor activation, but the depletion intensity profile differs by mineralocorticoid potency and dosing requirements. Prednisone's stronger mineralocorticoid activity drives more potassium and sodium disturbances than dexamethasone or methylprednisolone. According to CTD data, prednisone's 2,364 disease associations and the 14,894 PubMed articles indexed for this medication provide the most extensive evidence base for any corticosteroid nutrient interaction. Dexamethasone is 4-5x more potent per milligram, requiring lower doses that reduce total mineralocorticoid exposure. Prednisolone produces an identical depletion pattern because prednisone is its prodrug. Methylprednisolone offers a middle ground with less electrolyte disruption than prednisone but greater anti-inflammatory potency per milligram.
Food Sources for Depleted Nutrients
| Food | Amount per Serving |
|---|---|
| Sardines (with bones) | 325 mg per 3.5oz |
| Plain Greek yogurt | 230 mg per cup |
| Collard greens (cooked) | 266 mg per cup |
| Canned salmon (with bones) | 232 mg per 3.5oz |
| Almonds | 246 mg per quarter-cup |
Source: USDA Food Composition Database (658,209 food nutrient entries)
FAQ
References
- [1]Comparative Toxicogenomics Database (CTD): 39 prednisone gene interactions, 2,364 disease associations, 344 curated disease links (accessed April 2026)
- [2]ChEMBL Database: Prednisone classified as glucocorticoid receptor agonist (prodrug converted to prednisolone), with mineralocorticoid receptor cross-activity (accessed April 2026)
- [3]FAERS Database: Adverse event reporting for prednisone including osteoporosis, fractures, hyperglycemia, hypokalemia, and immune suppression events (accessed April 2026)
- [4]PubMed: 14,894 indexed articles for prednisone covering steroid-induced osteoporosis, diabetes, electrolyte disturbances, and immune complications (accessed April 2026)
- [5]PharmGKB Database: Pharmacogenomic annotations for prednisone affecting efficacy, toxicity, and metabolic outcomes (accessed April 2026)
- [6]Kelda Health Intelligence Platform: Cross-referenced analysis integrating CTD, ChEMBL, FAERS, PharmGKB, and PubMed datasets including 593 RCTs across 923,298 patients (accessed April 2026)
Check your medications
Check Free →